Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05179993Active Not Recruiting

Detection of Microplastics in Human Granulosa Cells and in the Follicular Fluid of Women Undergoing ICSI Treatment

Role: lead

NCT06447077Recruiting

Impact of a Predetermined Day 5 ET vs. a Predetermined Day 6 ET on Clinical Pregnancy Rate After ICSI Treatment

Role: lead

NCT03565107Completed

Characterization of Methylation Pattern in Human Germ Cells of Patients Undergoing ICSI Treatment

Role: lead

NCT03414567Completed

Presence of Toxins from Smoking in the Follicular Fluid of Women Undergoing Intracytoplasmic Sperm Injection Treatment

Role: lead

NCT01385605Completed

Analysis of Toxins in Follicle Fluid

Role: lead

NCT01385618Completed

Gene-polymorphisms Relating to Human Subfertility

Role: lead

All 6 trials loaded